MST1 and escherichia coli infection: Interestingly, loss of Mst1/2 or Mst1/2 kinases inhibitor treatment abrogated filopodia formation or actin accumulation at sites of bacteria induced by LPS or the Piezo1 agonist Yoda1 treatment or E. coli infection (Fig. 5a, b).